[go: up one dir, main page]

LU81002A1 - 2,3-dihydroimidazo(1,2-c)pyrimidines substituees et leur utilisation therapeutique - Google Patents

2,3-dihydroimidazo(1,2-c)pyrimidines substituees et leur utilisation therapeutique

Info

Publication number
LU81002A1
LU81002A1 LU81002A LU81002A LU81002A1 LU 81002 A1 LU81002 A1 LU 81002A1 LU 81002 A LU81002 A LU 81002A LU 81002 A LU81002 A LU 81002A LU 81002 A1 LU81002 A1 LU 81002A1
Authority
LU
Luxembourg
Prior art keywords
dihydroimidazo
therapeutic use
substituted pyrimidines
pyrimidines
substituted
Prior art date
Application number
LU81002A
Other languages
English (en)
Inventor
Wilson Turner William
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of LU81002A1 publication Critical patent/LU81002A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LU81002A 1978-03-09 1979-03-07 2,3-dihydroimidazo(1,2-c)pyrimidines substituees et leur utilisation therapeutique LU81002A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/884,884 US4153695A (en) 1978-03-09 1978-03-09 Substituted 2,3-dihydro imidazo[1,2-c]pyrimidines

Publications (1)

Publication Number Publication Date
LU81002A1 true LU81002A1 (fr) 1979-06-18

Family

ID=25385633

Family Applications (1)

Application Number Title Priority Date Filing Date
LU81002A LU81002A1 (fr) 1978-03-09 1979-03-07 2,3-dihydroimidazo(1,2-c)pyrimidines substituees et leur utilisation therapeutique

Country Status (14)

Country Link
US (1) US4153695A (fr)
EP (1) EP0004173B1 (fr)
JP (1) JPS54145697A (fr)
BE (1) BE874430A (fr)
CA (1) CA1105014A (fr)
CH (1) CH639092A5 (fr)
DE (1) DE2963706D1 (fr)
DK (1) DK96379A (fr)
FR (1) FR2419291A1 (fr)
GB (1) GB2016009B (fr)
HU (1) HU177992B (fr)
IE (1) IE48389B1 (fr)
IL (1) IL56746A (fr)
LU (1) LU81002A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4408047A (en) * 1980-03-28 1983-10-04 Merck & Co., Inc. Imidazodiazines
US4374988A (en) * 1981-11-05 1983-02-22 American Cyanamid Company 4-Heteroarylimidazo-[1,5-A]pyrimidines
US4503050A (en) * 1983-06-02 1985-03-05 Riker Laboratories, Inc. Substituted imidazo[1,2-c]pyrimidines
US4478835A (en) * 1983-08-02 1984-10-23 Riker Laboratories, Inc. Substituted imidazo[1,5-c]pyrimidines
US4473570A (en) * 1983-08-02 1984-09-25 Riker Laboratories, Inc. Imidazo[1,5-c]pyrimidin-5-ones
DE3638121A1 (de) * 1986-05-30 1987-12-03 Bayer Ag 1,2,3,6-tetrahydro-5-nitro-pyrimidin-derivate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2118261A1 (de) * 1971-04-15 1972-11-02 C.H. Boehringer Sohn, 6507 Ingelheim Neue N-haltige Bicyclen, deren Säureadditionssalze sowie Verfahren zu deren Herstellung
JPS523957B2 (fr) * 1974-03-14 1977-01-31

Also Published As

Publication number Publication date
DE2963706D1 (en) 1982-11-04
JPS54145697A (en) 1979-11-14
HU177992B (en) 1982-02-28
FR2419291A1 (fr) 1979-10-05
FR2419291B1 (fr) 1980-11-14
IE790579L (en) 1979-09-09
GB2016009A (en) 1979-09-19
IL56746A (en) 1982-08-31
EP0004173A1 (fr) 1979-09-19
CA1105014A (fr) 1981-07-14
US4153695A (en) 1979-05-08
EP0004173B1 (fr) 1982-09-22
IE48389B1 (en) 1985-01-09
BE874430A (fr) 1979-08-27
IL56746A0 (en) 1979-05-31
CH639092A5 (fr) 1983-10-31
DK96379A (da) 1979-09-10
GB2016009B (en) 1982-08-11

Similar Documents

Publication Publication Date Title
LU81439A1 (fr) Octahydro-pyrazolo(3,4-g)quinoleines et leur utilisation therapeutique
BE873883A (fr) 6-n-propyl-8-methoxymethyl ou methylmercaptomethylergolines et composes apparentes, et leur utilisation therapeutique
LU80922A1 (fr) 9-amino-et imino-dibenzopyrannes et leur utilisation therapeutique
BE877394A (fr) Phenethanolamines et leur utilisation therapeutique
FR2487349B1 (fr) Derives de l'hydronaphtalene, leur preparation et leur utilisation en therapeutique
BE872489A (fr) Derives heterosidiques de pleuromutiline et leur utilisation therapeutique
BE872134A (fr) Nouvelles indolo (2,3,a) quinolizidines, leur preparation et leur utilisation therapeutique
BE880220A (fr) 1,2,4,5-tetra-alkyl-4-arylpiperidines, leur utilisation therapeutique, leur preparation et les intermediaires appropries
FR2439197B1 (fr) 1-thia-3-aza-4-ones, substituees, leur preparation et leur utilisation en agriculture
BE882166A (fr) 9-aminoalkylfluorenes, leur preparation et leur utilisation therapeutique
BE887323A (fr) 17alpha-acyloxy-5 beta-corticoides et 17alpha-acyloxy-5alpha-corticoides, leur preparation et leur utilisation
LU81002A1 (fr) 2,3-dihydroimidazo(1,2-c)pyrimidines substituees et leur utilisation therapeutique
BE872990A (fr) Trans-4a-aryl-octahydro-1h-2-pyrindines et leur utilisation therapeutique
BE894056A (fr) 2-oxo-azetidines, leur preparation et leur utilisation
BE877263A (fr) 2-azaergolines et 2-aza-8 (ou 9) ergolenes et leur utilisation therapeutique
BE891585A (fr) 5 alpha-androstane-17 beta-carboxylates et 5 beta-androstane-17 beta-carboxylates, leur preparation et leur utilisation
BE866728A (fr) 1,2,4-triazoles, leur preparation et leur utilisation
LU81440A1 (fr) Octahydro-2h-pyrrolo(3,4-g)quinoleines et leur utilisation therapeutique
BE877390A (fr) R-n-(2-phenyl-2-hydroxyethyl)-3-phenylpropylamines et leur utilisation therapeutique
BE871724A (fr) 4-desacetoxy-4 alpha-hydroxyindole-dihydroindoles et leur utilisation therapeutique
LU81350A1 (fr) Arylalkyl-et aryloxyalkyl-phosphonates,leur preparation et leur utilisation therapeutique
BE882167A (fr) (1,1-biphenyl-2-yl)-propyl- et butylamines, leur preparation et leur utilisation therapeutique
BE891393A (fr) Esthers d'hydroxymethylpyrazines substituees leur preparation et leur utilisation therapeutique
BE874662A (fr) Benzocycloheptapyrannes et leur utilisation therapeutique
LU80161A1 (fr) 2,1-benzisothiazoles,leur preparation et leur utilisation therapeutique